Kleb Cerise, Faisal Muhammad Salman, Quintini Cristiano, Miller Charles M, Menon K V Narayanan, Modaresi Esfeh Jamak
Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH 44195, United States.
Department of General Surgery, Cleveland Clinic Foundation, Cleveland, OH 44195, United States.
World J Transplant. 2021 Oct 18;11(10):421-431. doi: 10.5500/wjt.v11.i10.421.
As the population of the United States ages, there has been an increasing number of elderly patients with cirrhosis listed for transplant. Previous studies have shown variable results in terms of the relative survival benefit for elderly liver transplant (LT) recipients. There may be factors that are associated with a poor post-transplant outcome which may help determine which elderly patients should and should not be listed for LT.
To identify factors associated with futility of transplant in elderly patients.
This was a retrospective study of all patients above the age of 45 who underwent liver transplantation at our tertiary care center between January 2010 and March 2020 ( = 1019). "Elderly" was defined as all patients aged 65 years and older. Futile outcome was defined as death within 90 d of transplant. Logistic regression analysis was performed to determine what variables, if any were associated with futile outcome in elderly patients. Secondary outcomes such as one year mortality and discharge to facility (such as skilled nursing facility or long-term acute care hospital) were analyzed in the entire sample, compared across three age groups (45-54, 55-64, and 65 + years).
There was a total of 260 elderly patients who received LT in the designated time period. A total of 20 patients met the definition of "futile" outcome. The mean Model of End-Stage Liver Disease scores in the futile and non-futile group were not significantly different (21.78 in the futile group 19.66 in the "non-futile" group). Of the variables tested, only congestive heart failure was found to have a statistically significant association with futile outcome in LT recipients over the age of 65 ( = 0.001). Of these patients, all had diastolic heart failure with normal ejection fraction and at least grade I diastolic dysfunction as measured on echocardiogram. Patients aged 65 years and older were more likely to have the outcomes of death within 1 year of LT [hazard ratio: 1.937, confidence interval (CI): 1.24-3.02, = 0.003] and discharge to facility (odds ratio: 1.94, CI: 1.4-2.8, < 0.001) compared to patients in younger age groups.
Diastolic heart failure in the elderly may be a predictor of futility post liver transplant in elderly patients. Elderly LT recipients may have worse outcomes as compared to younger patients.
随着美国人口老龄化,等待肝移植的老年肝硬化患者数量不断增加。先前的研究表明,老年肝移植受者的相对生存获益结果存在差异。可能存在一些与移植后不良结局相关的因素,这些因素有助于确定哪些老年患者应该或不应该被列入肝移植名单。
确定与老年患者移植无效相关的因素。
这是一项对2010年1月至2020年3月在我们三级医疗中心接受肝移植的所有45岁以上患者的回顾性研究(n = 1019)。“老年”定义为所有65岁及以上的患者。无效结局定义为移植后90天内死亡。进行逻辑回归分析以确定哪些变量(如果有的话)与老年患者的无效结局相关。在整个样本中分析了次要结局,如一年死亡率和转至医疗机构(如熟练护理机构或长期急性护理医院)的情况,并在三个年龄组(45 - 54岁、55 - 64岁和65岁及以上)之间进行比较。
在指定时间段内共有260名老年患者接受了肝移植。共有20名患者符合“无效”结局的定义。无效组和非无效组的终末期肝病平均评分无显著差异(无效组为21.78,“非无效”组为19.66)。在测试的变量中,仅发现充血性心力衰竭与65岁以上肝移植受者的无效结局有统计学显著关联(P = 0.001)。在这些患者中,所有患者均为舒张性心力衰竭,射血分数正常,且超声心动图测量至少为I级舒张功能障碍。与年轻年龄组的患者相比,65岁及以上的患者肝移植后1年内死亡[风险比:1.937,置信区间(CI):1.24 - 3.02,P = 0.003]和转至医疗机构(优势比:1.94,CI:1.4 - 2.8,P < 0.001)的可能性更高。
老年舒张性心力衰竭可能是老年患者肝移植后无效的预测指标。与年轻患者相比,老年肝移植受者可能有更差的结局。